Zepbound, a popular weight loss drug, has become the first FDA-approved prescription medication to treat obstructive sleep ...

Shares of ResMed and Inspire Medical Systems fell after the FDA approved Eli Lilly's weight-loss drug Zepbound to treat ...

Eli Lilly stock rose Monday after Zepbound received Food and Drug Administration (FDA) approval as a treatment for obstructive sleep apnea among adults with obesity.

Just eight seconds into the start of the 2025 award show season, Nikki Glaser, the host of the 82nd Golden Globes, dubbed the ...

Zepbound helps aid weight loss ... Share on Pinterest Design by MNT; Photography by andreswd/Getty Images & Bloomberg/Getty Images Design by MNT; Photography by Zorica Nastasic/Getty Images ...

The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA).

Former FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss the future of pharmaceutical advertising, health ...

Researchers from Canada reviewed the results of 26 trials to determine which of the weight loss jabs are the most effective ...

Comedian Nikki Glaser, host of the 2025 Golden Globe Awards ceremony, dove right in at the start of her opening monologue: ...

Right now, Novo stock is trading at a forward price-to-earnings (P/E) multiple of 22.5 -- its lowest level in well over a ...

Zepbound, Eli Lilly's (LLY ... (Jakub Porzycki/NurPhoto via Getty Images) · NurPhoto via Getty Images Amgen, meanwhile, reported 20% weight loss for once-monthly MariTide but saw sustained ...